Immunotherapy for Small Cell Lung Cancer: Current Challenges and Prospects

The authors summarize distinctive features of the tumor–immune microenvironment in small cell lung cancer and evaluate current immunotherapeutic strategies, notably immune checkpoint inhibitors, that have demonstrated survival benefits in a subset of patients.